Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis-Reference-Cited by-同舟云学术

Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis

Published:2018-12-01 Issue:1 Volume:7 Page:1-10
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Kussmann Manuel¹,Karer Matthias¹,Obermueller Markus¹,Schmidt Katy²,Barousch Wolfgang³,Moser Doris⁴,Nehr Marion³,Ramharter Michael¹⁵,Poeppl Wolfgang¹⁶,Makristathis Athanasios³,Winkler Stefan¹,Thalhammer Florian¹,Burgmann Heinz¹,Lagler Heimo¹

Affiliation:

1. Department of Medicine IDivision of Infectious Diseases and Tropical Medicine, Medical University of Vienna Vienna Austria

2. Center for Anatomy and Cell Biology, Division of Cell and Developmental BiologyMedical University of Vienna Vienna Austria

3. Department of Laboratory Medicine, Division of Clinical MicrobiologyMedical University of Vienna Vienna Austria

4. Department of Cranio-Maxillofacial and Oral SurgeryMedical University of Vienna Vienna Austria

5. Department of Tropical Medicine; Bernhard Nocht Institute for Tropical Medicine & I. Dep. Of MedicineUniversity Medical Center Hamburg-Eppendorf Hamburg Germany

6. Military Medical Cluster EastAustrian Armed Forces Vienna Austria

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

http://www.nature.com/articles/s41426-018-0205-z.pdf

Reference56 articles.

1. FINAL draft Label - dalvance_pi. https://www.allergan.com/assets/pdf/dalvance_pi. Accessed 11th Sept 2017.

2. New Lipoglycopeptides

3. Dalbavancin: a novel antimicrobial

4. Structure-activity relationships of vancomycin-type glycopeptide antibiotics.